Terns Pharmaceuticals, Inc.

NasdaqGS:TERN Stok Raporu

Piyasa değeri: US$491.8m

Terns Pharmaceuticals Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Terns Pharmaceuticals'in kazancının yıllık 14.7% oranında azalması, yıllık gelirinin ise yıllık 76.6% oranında artması beklenmektedir. EPS'nin düşmesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde -71.6% olacağı tahmin edilmektedir.

Anahtar bilgiler

-14.7%

Kazanç büyüme oranı

-8.7%

EPS büyüme oranı

Pharmaceuticals kazanç büyümesi23.9%
Gelir büyüme oranı76.6%
Gelecekteki özkaynak getirisi-71.6%
Analist kapsamı

Good

Son güncelleme22 Nov 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Terns Pharmaceuticals: Another Potential GLP-1 Entrant

Oct 21

Terns Pharmaceuticals: Obesity Advancement Continues With Other Q1 2025 Program Catalyst

Sep 25

Terns Pharmaceuticals: Weight Loss Drug TERN-601 Is Competitive

Sep 10

We Think Terns Pharmaceuticals (NASDAQ:TERN) Can Afford To Drive Business Growth

Aug 18
We Think Terns Pharmaceuticals (NASDAQ:TERN) Can Afford To Drive Business Growth

Terns Pharmaceuticals (NASDAQ:TERN) Is In A Good Position To Deliver On Growth Plans

May 03
Terns Pharmaceuticals (NASDAQ:TERN) Is In A Good Position To Deliver On Growth Plans

Terns Pharmaceuticals (NASDAQ:TERN) Is In A Good Position To Deliver On Growth Plans

Jan 12
Terns Pharmaceuticals (NASDAQ:TERN) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That Terns Pharmaceuticals (NASDAQ:TERN) Will Use Its Cash Wisely

Sep 29
We're Hopeful That Terns Pharmaceuticals (NASDAQ:TERN) Will Use Its Cash Wisely

Companies Like Terns Pharmaceuticals (NASDAQ:TERN) Are In A Position To Invest In Growth

Jun 06
Companies Like Terns Pharmaceuticals (NASDAQ:TERN) Are In A Position To Invest In Growth

Companies Like Terns Pharmaceuticals (NASDAQ:TERN) Are In A Position To Invest In Growth

Feb 21
Companies Like Terns Pharmaceuticals (NASDAQ:TERN) Are In A Position To Invest In Growth

Companies Like Terns Pharmaceuticals (NASDAQ:TERN) Are In A Position To Invest In Growth

Oct 03
Companies Like Terns Pharmaceuticals (NASDAQ:TERN) Are In A Position To Invest In Growth

Terns Pharmaceuticals: The Easy Money Has Been Made

Sep 20

Terns Pharmaceuticals GAAP EPS of -$0.55 beats by $0.08

Aug 08

Is Terns Pharmaceuticals (NASDAQ:TERN) In A Good Position To Deliver On Growth Plans?

Jun 14
Is Terns Pharmaceuticals (NASDAQ:TERN) In A Good Position To Deliver On Growth Plans?

Companies Like Terns Pharmaceuticals (NASDAQ:TERN) Are In A Position To Invest In Growth

Mar 16
Companies Like Terns Pharmaceuticals (NASDAQ:TERN) Are In A Position To Invest In Growth

We're Not Very Worried About Terns Pharmaceuticals' (NASDAQ:TERN) Cash Burn Rate

Nov 24
We're Not Very Worried About Terns Pharmaceuticals' (NASDAQ:TERN) Cash Burn Rate

We're Hopeful That Terns Pharmaceuticals (NASDAQ:TERN) Will Use Its Cash Wisely

Aug 24
We're Hopeful That Terns Pharmaceuticals (NASDAQ:TERN) Will Use Its Cash Wisely

Terns Pharma gains 9% on positive TERN-101 data in mid-stage NASH study

Jun 14

Kazanç ve Gelir Büyüme Tahminleri

NasdaqGS:TERN - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/20262-144-114-1346
12/31/2025N/A-120-97-1038
12/31/2024N/A-92-87-818
9/30/2024N/A-88-75-75N/A
6/30/2024N/A-96-79-79N/A
3/31/2024N/A-91-76-76N/A
12/31/2023N/A-90-67-67N/A
9/30/2023N/A-85-59-59N/A
6/30/2023N/A-72-52-52N/A
3/31/2023N/A-68-50-50N/A
12/31/2022N/A-60-49-49N/A
9/30/20221-59-49-49N/A
6/30/20221-54-44-43N/A
3/31/20221-51-41-41N/A
12/31/20211-50-42-42N/A
9/30/2021N/A-35-39-39N/A
6/30/2021N/A-35-37-37N/A
3/31/2021N/A-34-37-37N/A
12/31/2020N/A-29-30-30N/A
9/30/2020N/A-40-33-32N/A
12/31/2019N/A-69-67-66N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: TERN önümüzdeki 3 yıl boyunca kârsız kalmaya devam edeceği tahmin ediliyor.

Kazançlar ve Piyasa: TERN önümüzdeki 3 yıl boyunca kârsız kalmaya devam edeceği tahmin ediliyor.

Yüksek Büyüme Kazançları: TERN önümüzdeki 3 yıl boyunca kârsız kalmaya devam edeceği tahmin ediliyor.

Gelir ve Pazar: TERN gelecek yıl gelir elde edemeyeceği tahmin ediliyor.

Yüksek Büyüme Geliri: TERN gelecek yıl gelir elde edemeyeceği tahmin ediliyor.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: TERN 3 yıl içinde kârsız olması bekleniyor.


Büyüyen şirketleri keşfedin